QURALIS

quralis-logo

QurAlis is a operator of a biotechnology company intended to discover and develop potential precision therapeutics for amyotrophic lateral sclerosis (ALS). The company focuses on the link between genetics and disease in ALS and other neurological diseases, enabling doctors to successfully treat ALS .

#SimilarOrganizations #People #Financial #Website #More

QURALIS

Social Links:

Industry:
Biotechnology Health Care Therapeutics

Founded:
2016-12-12

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.quralis.com

Total Employee:
1+

Status:
Active

Contact:
(+1) 617.682.6015

Email Addresses:
[email protected]

Total Funding:
47.5 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Google Universal Analytics Font Awesome


Similar Organizations

1859-logo

1859

1859 is a biotechnology company focusing on the discovery and development of next-generation therapeutics.

amplo-biotechnology-logo

Amplo Biotechnology

Amplo Biotechnology is to develop multiple, potentially curative, Adeno-Associated Viral (AAV) therapies for the neuromuscular junction.

amyloid-solution-logo

Amyloid Solution

Amyloid Solution is a developer of therapy intended to overcome Alzheimer by developing modifying treatments.

arbor-biotechnologies-logo

Arbor Biotechnologies

Arbor Biotechnologies is an operator of a bio-discovery company intended to provide human diagnostic development services.

biopalette-logo

Biopalette

Biopalette is a operator of a platform intended to offer gene-editing techniques.

bridgene-biosciences-logo

BridGene Biosciences

BridGene Biosciences is a biotechnology company using cutting-edge chemoproteomic technology to discover and develop small molecules.

cedilla-therapeutics-logo

Cedilla Therapeutics

Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.

deepbiome-therapeutics-logo

DeepBiome Therapeutics

DeepBiome Therapeutics is an operator of a biotechnology company intended to develop a new drug discovery platform.

disarm-therapeutics-logo

Disarm Therapeutics

Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.

elstar-therapeutics-logo

Elstar Therapeutics

Fulfilling the promise of precision cancer immunotherapy through a powerful new approach to generating multi-functional therapeutics.

goldfinch-biopharma-logo

Goldfinch Biopharma

Goldfinch is a clinical-stage biotech company focused on discovering and developing precision therapies for patients with kidney disease.

ideaya-biosciences-logo

IDEAYA Biosciences

IDEAYA Biosciences is an oncology-focused biotechnology company committed to the discovery of breakthrough synthetic lethality

illuminare-biotechnologies-logo

Illuminare Biotechnologies

Illuminare Biotechnologies is a operator of a biotechnology company intended to reduce risk of nerve damage during surgery.

latigo-biotherapeutics-logo

Latigo Biotherapeutics

Operator of a drug discovery company intended to develop novel, non-opioid therapies for chronic pain.

maze-therapeutics-logo

Maze Therapeutics

Maze Therapeutics is an operator of a biotechnology firm used to focus on translating genetic insights into new medicines.

microbiotica-logo

Microbiotica

Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers.

ncardia-logo

Ncardia

Ncardia is an Operator of a biotechnology company intended to expedite drug discovery and development process.

raze-therapeutics-logo

Raze Therapeutics

Raze Therapeutics, Inc., a biotechnology company, engages in the discovery and development of oncology therapeutics.

ribon-therapeutics-logo

Ribon Therapeutics

Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.

semarion-logo

Semarion

Semarion leverages microfabrication technology to build smart materials and develop novel cell assaying applications.

speratum-logo

Speratum

Speratum is a biotechnology company dedicated to research and development (R&D) of targeted molecular therapies for cancer treatment.

vigil-neuroscience-logo

Vigil Neuroscience

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.

viralytics-logo

Viralytics

Viralytics is an Australian biotechnology company, listed on the Australian Stock Exchange (ASX:VLA) and is quoted on the OTC market


Current Advisors List

anthony-walsh_image

Anthony Walsh Board Observer @ QurAlis
Board_observer
2018-08-01

johannes-fruehauf_image

Johannes Fruehauf Board Member, Chair of compensation committee @ QurAlis
Board_member
2018-01-01

jeffrey-moore_image

Jeffrey Moore Board of Directors @ QurAlis
Board_member

jonathan-j-fleming_image

Jonathan J. Fleming Chairman Of The Board @ QurAlis
Board_member
2017-01-01

sudhir-agrawal_image

Sudhir Agrawal Member, Scientific Advisory Board @ QurAlis
Board_member
2019-01-01

Current Employees Featured

clifford-j-woolf_image

Clifford J Woolf
Clifford J Woolf Founder @ QurAlis
Founder

kasper-roet_image

Kasper Roet
Kasper Roet Founder and CEO @ QurAlis
Founder and CEO
2017-01-01

kevin-eggan_image

Kevin Eggan
Kevin Eggan Founder @ QurAlis
Founder
2017-01-01

Founder


clifford-j-woolf_image

Clifford J Woolf

kasper-roet_image

Kasper Roet

kevin-eggan_image

Kevin Eggan

Investors List

mitsui-ventures_image

Mitsui Global Investment

Mitsui Global Investment investment in Series A - QurAlis

sanford-biosciences_image

Sanford Biosciences

Sanford Biosciences investment in Series A - QurAlis

droia_image

Droia Ventures

Droia Ventures investment in Series A - QurAlis

ls-polaris-innovation-fund_image

LS Polaris Innovation Fund

LS Polaris Innovation Fund investment in Series A - QurAlis

mp-healthcare-venture-management-inc_image

MP Healthcare Venture Management

MP Healthcare Venture Management investment in Series A - QurAlis

inkef-capital_image

Inkef

Inkef investment in Series A - QurAlis

bioinnovation-capital_image

Mission BioCapital

Mission BioCapital investment in Series A - QurAlis

dolby-family-ventures_image

Dolby Family Ventures

Dolby Family Ventures investment in Series A - QurAlis

amgen-ventures_image

Amgen Ventures

Amgen Ventures investment in Series A - QurAlis

dementia-discovery_image

Dementia Discovery Fund

Dementia Discovery Fund investment in Series A - QurAlis

Official Site Inspections

http://www.quralis.com Semrush global rank: 3.71 M Semrush visits lastest month: 3.72 K

  • Host name: 141.193.213.11
  • IP address: 141.193.213.11
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "QurAlis"

QurAlis - Crunchbase Company Profile & Funding

QurAlis is a clinical-stage biotechnology company that is developing precision medicines with genetically validated targets for amyotrophic lateral sclerosis โ€ฆSee details»

Our Story - QurAlis

Our Story We now have an unprecedented deep understanding of the disease and the disease mechanisms which creates an opportunity to realize real treatment breakthroughs.See details»

People - QurAlis

Mar 12, 2025 Immediately prior to joining QurAlis, Robin was head of global patient safety at FibroGen, where she led a major initiative to drive an organizational modernization agenda in โ€ฆSee details»

Quiver Bioscience and QurAlis Announce Research Collaboration โ€ฆ

37 minutes ago CAMBRIDGE, Mass., May 15, 2025--Quiver Bioscience and QurAlis Announce Research Collaboration to Advance Novel Therapeutic Approach for Fragile X SyndromeSee details»

QurAlis Corporation - MassBio

QurAlis Corporation: Neuro Pioneers on a Quest to Cure At QurAlis, we consider ourselves โ€œneuro pioneersโ€ because we are driven to explore the deepest aspects of human neurology in order to find the treatments patients urgently need. We โ€ฆSee details»

QurAlis - EQT Group

Do You Want to Know More? We are eager to explore how we can achieve great things together.See details»

Quralis Corporation Company Profile | Cambridge, MA

Find company research, competitor information, contact details & financial data for Quralis Corporation of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.See details»

QurAlis Expands Leadership Team With Doug โ€ฆ

Jun 11, 2024 โ€œQurAlis is a mission-driven organization dedicated to bringing transformative therapies to patients with ALS and other serious neurodegenerative diseases,โ€ said Mr. Brown.See details»

QurAlis - VentureRadar

"QurAlis is developing precision therapeutics for ALS, a terminal disease that causes muscle paralysis through degeneration of the motor system. We are digging deep into the root causes โ€ฆSee details»

QurAlis - LinkedIn

QurAlis' CEO and founder, Kasper Roet, was a featured speaker at the Innovation for Health 2025 conference held last week in Rotterdam.See details»

How Does QurAlis Work? โ€“ CANVAS, SWOT, PESTEL & BCG Matrix โ€ฆ

Oct 2, 2024 QurAlis is a biotechnology company that is dedicated to developing precision medicine solutions to cure ALS and FTD. By leveraging cutting-edge research and technology, โ€ฆSee details»

Quiver Bioscience and QurAlis Announce Research Collaboration โ€ฆ

39 minutes ago In addition to ALS, QurAlis is advancing a robust precision medicine pipeline to bring effective disease-modifying therapeutics to patients suffering from severe diseases โ€ฆSee details»

QurAlis - Golden

QurAlis is a biotechnology company developing treatments for amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).See details»

QurAlis Strengthens Global Presence With Opening of European ...

Jan 3, 2024 QurAlis is currently advancing a pipeline with therapeutic candidates that target specific components of ALS pathology and defined ALS patient populations based on both โ€ฆSee details»

QurAlis - Contacts, Employees, Board Members, Advisors & Alumni

QurAlis is a biotechnology company that creates precision medicine solutions to cure ALS and FTD.See details»

QurAlis - The Org

QurAlis is developing precision therapeutics for ALS, a terminal disease that causes muscle paralysis through degeneration of the motor system. They are digging deep into the root โ€ฆSee details»

QurAlis Company Profile - Office Locations, Competitors ... - Craft

QurAlis has 5 employees at their 1 location and $47.5 m in total funding,. See insights on QurAlis including office locations, competitors, revenue, financials, executives, subsidiaries and more โ€ฆSee details»

QurAlis : GoodLab

QurAlis is boldly seeking to translate scientific breakthroughs into powerful precision medicines that have the potential to transform the lives of people living with neurodegenerative and โ€ฆSee details»

QurAlis to Present at the Stifel 2024 CNS Days - QurAlis

Mar 12, 2024 At QurAlis, we are neuro pioneers on a quest to cure. We work with a relentless pursuit of knowledge, a precise attention to craft, and an optimistic mindset to discover and โ€ฆSee details»

QurAlis - Work in biotech

QurAlis is using advances in precision medicine to develop therapeutics for neurodegenerative diseases. Amyotrophic lateral sclerosis (ALS), is a progressive neurodegenerative disease โ€ฆSee details»

linkstock.net © 2022. All rights reserved